Illumina inc stock.

Stock Information; Corporate Governance; All Investor Information. 25 years of innovation. ... we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics. All trademarks are the property ...

Illumina inc stock. Things To Know About Illumina inc stock.

Jul 12, 2023 · Nov 27. Nov 2014 2016 2018 2020 2022 75 100 125 150 175 0 2.5M 5M 7.5M 10M. XNAS:ILMN,NASDAQ:ILMN historical stock data. Stock Date. Stock Price. November 30, 2023. $101.95. November 29, 2023. $101.57. SAN DIEGO, March 27, 2023 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced the release of Connected Insights, a new cloud-based software enabling tertiary analysis for clinical next-generation sequencing (NGS) data.Find the latest Illumina, Inc. (ILMN) stock quote, history, news and other vital information to help you with your stock trading and investing.Illumina, Inc. stock has a Growth Score of 90, Momentum Score of 24 and Quality Score of 49. Comparing Danaher Corporation, Illumina and Inc.’s grades, scores and metrics can act as a solid basis to determine whether they may be a good investment or not.Illumina 's ( ILMN -0.92%) stock is down by 15% this year so far, and it's no surprise why. With the new disclosure of a Securities and Exchange Commission (SEC) investigation into its bedraggled ...

THE LAWSUIT: A class action securities lawsuit was filed against Illumina, Inc. that seeks to recover losses of shareholders who were adversely affected by alleged securities fraud between May 1, 2023 and October 16, 2023. CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (1) …

Get the latest Illumina, Inc. (ILMN) stock news and headlines to help you in your trading and investing decisions.

Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics. Illumina Korea Hi Investment & Securities building 66 Yeoidaero Yeoungdeungpo-gu Seoul Korea 07325 This is more than 2x the current stock price of $119.47. Let’s assume Illumina decides to spin-off Grail to shareholders, needs to raise $1 billion in capital, and we choose equity because debt ...Dec 4, 2023 · NEW YORK, NY / ACCESSWIRE / December 4, 2023 / If you suffered a loss on your Illumina, Inc. (NASDAQ:ILMN) investment and want to learn about a potential recovery under the federal securities laws ... Illumina, Inc. Stock Price History. Illumina, Inc.’s price is currently down 13% so far this month. During the month of November, Illumina, Inc.’s stock price has reached a high of $118.38 and a low of $89.00. Over the last year, Illumina, Inc. has hit prices as high as $238.71 and as low as $89.00. Year to date, Illumina, Inc.’s stock is ...

Dec 1, 2023 · The low in the last 52 weeks of Illumina stock was 89.01. According to the current price, Illumina is 122.47% away from the 52-week low. What was the 52-week high for Illumina stock?

Illumina, Inc. is a provider of sequencing- and array-based solutions for genetic and genomic analysis. The Company operates through two segments: Core Illumina and GRAIL. ... Webull offers Illumina, Inc. stock information, including NASDAQ: ILMN real-time market quotes, financial reports, professional analyst ratings, in-depth charts ...

0.67%. $6.69B. Invitae Corp. 0.66%. $155.59M. ILMN | Complete Illumina Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.9.12M. BABA. 72.93. -2.60%. 9.87M. View today's Illumina Inc stock price and latest ILMN news and analysis. Create real-time notifications to follow any changes in the live stock price.Illumina, Inc. stock has a Growth Score of 90, Momentum Score of 24 and Quality Score of 49. Comparing Danaher Corporation, Illumina and Inc.’s grades, scores and metrics can act as a solid basis to determine whether they may be a good investment or not.Key statistics. On Monday, Illumina Inc (ILMN:NSQ) closed at 94.65, 6.35% above its 52-week low of 89.00, set on Nov 10, 2023. Data delayed at least 15 minutes, as of Nov 27 2023 21:00 GMT. Latest Illumina Inc (ILMN:NSQ) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more.Illumina, Inc. Common Stock (ILMN) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.If you’re just getting started, tracking investments might seem like a mystery. Thankfully, modern tools and technology make it easier than ever to figure out how to manage your stock portfolio and to track it. This quick guide gives you ti...

Illumina, Inc. Stock Price History. Illumina, Inc.’s price is currently down 13% so far this month. During the month of November, Illumina, Inc.’s stock price has reached a high of $118.38 and a low of $89.00. Over the last year, Illumina, Inc. has hit prices as high as $238.71 and as low as $89.00. Year to date, Illumina, Inc.’s stock is ...Get the latest Illumina, Inc. (ILU) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Law Offices of Howard G. Smith reminds investors of the upcoming January 9, 2024 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Illumina, Inc. (“Illumina” or the “Company”) (NASDAQ: ILMN) securities between May 1, 2023 and October 16, 2023, inclusive (the “Class Period”).. Investors …The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of California against Illumina, Inc. (“Illumina”) (NASDAQ: ILMN).The action charges Illumina with violations of the federal securities …See the company profile for Illumina, Inc. (ILMN) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and their ...Get the latest Illumina, Inc. (ILMN) stock news and headlines to help you in your trading and investing decisions.

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic ... Illumina (ILMN) Stock Key Data. Summary ...Get the latest Illumina, Inc. (ILU) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

Illumina Inc. analyst ratings, historical stock prices, earnings estimates & actuals. ILMN updated stock price target summary.This 38% fall for ILMN stock since late 2019 can primarily be attributed to 1. the company’s P/S ratio falling 50% to 6.8x trailing revenues now, vs. 13.7x in 2019, 2. a 7.2% rise in its average ...Robbins LLP reminds investors that a shareholder filed a class action lawsuit on behalf of persons and entities that purchased or otherwise acquired Illumina, Inc. (NASDAQ: ILMN) securities between May 1, 2023 and October 16, 2023. Illumina is a genetic and genomic analysis company with a portfolio of integrated sequencing and …General Inquiries. Salli Schwartz, Vice President lllumina Investor Relations 5200 Illumina Way San Diego, CA 92122. 858.291.6421 [email protected] Inc Stock Forecast and Price Target. According to fourteen experts, who recently provided their 2023 price targets for Illumina Inc, the average price target is $140.00, with a high estimate of $260.00 and a low estimate of $50.00. That is a potential upside of approximately 37.32% from the last closing price of $101.95 on November, 2023.Scores. Illumina has an Altman Z-Score of 2.44 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy. Detailed statistics for …Weaker Guidance Dragged Illumina (ILMN) in Q3. (Insider Monkey) Nov-16-23 04:50PM. Illumina: Company Investigated by the Portnoy Law Firm. (GlobeNewswire) 10:15AM. Lowey Dannenberg, P.C. is Investigating Illumina, Inc. (NASDAQ: ILMN) for Potential Breaches of Fiduciary Duty by Its Board of Directors. Transcript : Illumina, Inc. Presents at Piper Sandler 35th Annual Healthcare Conference, Nov-29-2023 11:30 AM Nov. 29: CI Transcript : Illumina, Inc. Presents at The 6th Annual Evercore ISI HealthCONx Conference, Nov-28-2023 10:50 AM Nov. 28: CI

Illumina stock recovered Thursday after the company torched its outlook on company-specific and macro headwinds.At the close, ILMN stock sank back below its 50-day line.. X. Illumina is a leader ...

Date. Title. Nov 14, 2023. Illumina To Webcast Upcoming Investor Conferences. Nov 13, 2023. Illumina launches Global Health Access Initiative to support acceleration of pathogen sequencing in low- and middle-income countries. Nov 9, 2023. Illumina Reports Financial Results for Third Quarter of Fiscal Year 2023. View All Press Releases.

Illumina Inc (ILMN) is a leading provider of tools and services for genetic analysis and sequencing. The stock price, news, and analysis of ILMN are updated daily on Morningstar, including its rating, valuation, sustainability, and performance. See how ILMN compares to its competitors and the healthcare industry.You may have a lot of questions if you are interested in investing in the stock market for the first time. One question that beginning investors often ask is whether they need a broker to begin trading.Illumina, Inc. Stock Price History. Illumina, Inc.’s price is currently down 13% so far this month. During the month of November, Illumina, Inc.’s stock price has reached a high of $118.38 and a low of $89.00. Over the last year, Illumina, Inc. has hit prices as high as $238.71 and as low as $89.00. Year to date, Illumina, Inc.’s stock is ...Stock analysis for Illumina Inc (ILMN:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.Innovative technologies. At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers.Illumina for Startups initiatives include Illumina Accelerator, founded in 2014, and Sequoia Capital China Intelligent Healthcare Genomics Incubator, Powered by Illumina, launching Fall 2021. Illumina Accelerator is a company creation engine co-located with Illumina research and development sites in San Francisco Bay Area and Cambridge, UK.Overall, Revvity Inc stock has a Growth Score of 90, Momentum Score of 36 and Quality Score of 68. Illumina, Inc. stock has a Growth Score of 90, Momentum Score of 17 and Quality Score of 49. Comparing Revvity Inc, Illumina and Inc.’s grades, scores and metrics can act as a solid basis to determine whether they may be a good investment or not.Illumina, Inc. stock has a Growth Score of 90, Momentum Score of 15 and Estimate Revisions Score of 62. Comparing Agilent Technologies Inc, Illumina and Inc.’s grades, scores and metrics can act as a solid basis to determine whether they may be a good investment or not.Illumina Inc. Stock Performance and Analysis: October 11, 2023. On October 11, 2023, Illumina Inc. (ILMN) had a previous close of $138.79 and opened at $139.73. Throughout the day, the stock’s range fluctuated between $136.66 and $139.73. The trading volume for the day was 29,406 shares, significantly lower than the average …

SAN DIEGO, April 25, 2023 /PRNewswire/ -- Illumina, Inc. (Nasdaq: ILMN) ("Illumina" or the "company") today announced its financial results for the first quarter of fiscal year 2023, which include the consolidated financial results for GRAIL.Date. Title. Nov 14, 2023. Illumina To Webcast Upcoming Investor Conferences. Nov 13, 2023. Illumina launches Global Health Access Initiative to support acceleration of pathogen sequencing in low- and middle-income countries. Nov 9, 2023. Illumina Reports Financial Results for Third Quarter of Fiscal Year 2023. View All Press Releases.CGP can offer both actionable and potentially actionable results to help identify more effective therapeutic paths and innovative clinical trial options for cancer patients. When tissue biopsies are unavailable, CGP from liquid biopsy may provide helpful information about a tumor's genomic make-up. CGP using tissue and liquid biopsy together ...Instagram:https://instagram. reit investment platformtruist financial corpxbox 360 console trade in valuesector spiders Understanding stock price lookup is a basic yet essential requirement for any serious investor. Whether you are investing for the long term or making short-term trades, stock price data gives you an idea what is going on in the markets.Find the latest historical data for Illumina, Inc. Common Stock (ILMN) at Nasdaq.com. what is the best platform to trade futuresbest mortgage lenders mn 0.67%. $6.69B. Invitae Corp. 0.66%. $155.59M. ILMN | Complete Illumina Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. tequila stocks Illumina, Inc. Stock Price History. Illumina, Inc.’s price is currently down 13% so far this month. During the month of November, Illumina, Inc.’s stock price has reached a high of $118.38 and a low of $89.00. Over the last year, Illumina, Inc. has hit prices as high as $238.71 and as low as $89.00. Year to date, Illumina, Inc.’s stock is ...Aug 18, 2021 · The base stock consideration was subject to a collar, where the number of shares issued at closing varied in the event the 20-trading-day volume weighted average price of Illumina stock as of 10 trading days prior to closing is between $295 and $399 but was fixed at 11.3 million shares if such volume weighted average share price is above $399 ... (jj) “Predecessor Plan” means the Illumina, Inc. 2005 Stock and Incentive Plan, as amended and restated. (kk) “ Outstanding Qualified Performance-Based Compensation ” means any compensation granted prior to November 3, 2017 and that is outstanding as of the Effective Date and is intended to constitute “qualified performance-based ...